Clinical Trials Directory

Trials / Completed

CompletedNCT01851863

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia: A Randomized Comparison of Different Prescribing Behaviors

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
262 (actual)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The study hypothesis is appropriate clinician-patient communication that provides explanations of the reasons for psychoactive drug prescriptions based on the generation of FD symptoms and the drugs' effects might improve compliance with psychoactive agent regimens among FD patients.

Detailed description

Antidepressive agents have been proved to be effective in the treatment of functional dyspepsia (FD) patients. However, one of the factors that limit therapeutic benefit is the poor compliance with prescribed drugs. The possible reasons for lack of compliance include the patient's health beliefs (e.g., that people who took such agents is possibly considered insane in China), lack of knowledge about antidepressants (that they are addictive or can be stopped on recovery), and aversion to side effects. The investigators propose to examine whether different clinician-patient communication methods could affect adherence to antidepressant drugs in functional dyspepsia patients.

Conditions

Interventions

TypeNameDescription
DRUGOmeprazolePrescribe Omeprazole(20mg, po, qd, 30min before breakfast).
DRUGFlupentixol-Melitracen(psychological and GI) + OmeprazolePrescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast).The patients were told that: GI symptoms in FD are attributable to both psychological and GI mechanisms. Flupentixol-Melitracen relieves FD symptoms through both psychological and GI mechanisms.
DRUGFlupentixol-Melitracen(psychological) + OmeprazolePrescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast). The patients were told that: GI symptoms were attributable to somatization of their psychological problems; and Flupentixol-Melitracen is an antipsychotic drug and primarily acts centrally to alleviate FD symptoms by regulating the psychological condition.
DRUGFlupentixol-Melitracen(without explanation) + OmeprazolePrescribe Flupentixol and Melitracen Tablets(one tablet, po, qd, 1 hour after breakfast) and Omeprazole (20mg, po, qd, 30min before breakfast). The patients were told only that Flupentixol-Melitrace has been proven to be effective in FD treatment and were not provided additional explanations of the relationships between their GI symptoms and their psychological condition and the reasons for the prescription of Flupentixol-Melitrace.

Timeline

Start date
2013-05-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2013-05-13
Last updated
2015-02-23
Results posted
2015-02-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01851863. Inclusion in this directory is not an endorsement.